Published in Lancet Infect Dis on October 03, 2011
Contraception and prevention of HIV transmission: a potential conflict of public health principles. J Fam Plann Reprod Health Care (2014) 2.08
Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis. PLoS Med (2015) 1.61
Assessing the effect of hormonal contraception on HIV acquisition in observational data: challenges and recommended analytic approaches. AIDS (2013) 1.34
Effect of progestins on immunity: medroxyprogesterone but not norethisterone or levonorgestrel suppresses the function of T cells and pDCs. Contraception (2014) 1.15
Injectable and oral contraceptives and risk of HIV acquisition in women: an analysis of data from the MDP301 trial. Hum Reprod (2014) 0.98
What works to meet the sexual and reproductive health needs of women living with HIV/AIDS. J Int AIDS Soc (2011) 0.91
Medroxyprogesterone acetate and levonorgestrel increase genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infection. Mucosal Immunol (2016) 0.86
Living with uncertainty: acting in the best interests of women. AIDS Res Treat (2012) 0.84
Awareness and interest in intrauterine contraceptive device use among HIV-positive women in Cape Town, South Africa. Infect Dis Obstet Gynecol (2012) 0.79
The impact of oral contraceptive initiation on young women's condom use in 3 American cities: missed opportunities for intervention. PLoS One (2014) 0.75
Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis (2011) 10.96
Preexposure prophylaxis for HIV infection among African women. N Engl J Med (2012) 15.28
Magnesium sulfate tocolysis: time to quit. Obstet Gynecol (2006) 5.11
Tenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trial. PLoS Clin Trials (2007) 4.93
SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria. PLoS One (2008) 3.45
The Good Clinical Practice guideline: a bronze standard for clinical research. Lancet (2005) 2.81
SAVVY (C31G) gel for prevention of HIV infection in women: a Phase 3, double-blind, randomized, placebo-controlled trial in Ghana. PLoS One (2007) 2.41
Is this woman perimenopausal? JAMA (2003) 1.31
Safety of hormonal and intrauterine methods of contraception for women with HIV/AIDS: a systematic review. AIDS (2009) 1.08
Validation of a job aid to rule out pregnancy among family planning clients in Nicaragua. Rev Panam Salud Publica (2008) 1.02
Progestogen-only contraceptive use among breastfeeding women: a systematic review. Contraception (2010) 0.97
Effectiveness of hormonal contraception in HIV-infected women using antiretroviral therapy. AIDS (2015) 0.97
Contraceptive effectiveness of a polyurethane condom and a latex condom: a randomized controlled trial. Obstet Gynecol (2003) 0.93
20 µg versus >20 µg estrogen combined oral contraceptives for contraception. Cochrane Database Syst Rev (2013) 0.89
Internucleotide movements during formation of 16 S rRNA-rRNA photocrosslinks and their connection to the 30 S subunit conformational dynamics. J Mol Biol (2005) 0.85
Safety of quinacrine contraceptive pellets: results from 10-year follow-up in Vietnam. Contraception (2008) 0.85
Contraceptive effectiveness of two insertions of quinacrine: results from 10-year follow-up in Vietnam. Contraception (2008) 0.84
Steroid hormones for contraception in men. Cochrane Database Syst Rev (2012) 0.84
Women's ability to self-screen for contraindications to combined oral contraceptive pills in Tanzanian drug shops. Int J Gynaecol Obstet (2013) 0.83
20 µg versus >20 µg estrogen combined oral contraceptives for contraception. Cochrane Database Syst Rev (2011) 0.83
Twenty micrograms vs. >20 microg estrogen oral contraceptives for contraception: systematic review of randomized controlled trials. Contraception (2005) 0.82
Pregnancy and contraceptive use among women participating in the FEM-PrEP trial. J Acquir Immune Defic Syndr (2015) 0.82
Chikungunya virus host range E2 transmembrane deletion mutants induce protective immunity against challenge in C57BL/6J mice. J Virol (2013) 0.81
Structural mutants of dengue virus 2 transmembrane domains exhibit host-range phenotype. Virol J (2011) 0.81
Testing of novel dengue virus 2 vaccines in African green monkeys: safety, immunogenicity, and efficacy. Am J Trop Med Hyg (2012) 0.80
Liver and renal safety of tenofovir disoproxil fumarate in combination with emtricitabine among African women in a pre-exposure prophylaxis trial. BMC Pharmacol Toxicol (2014) 0.79
Conformational change in the 16S rRNA in the Escherichia coli 70S ribosome induced by P/P- and P/E-site tRNAPhe binding. Biochemistry (2003) 0.78
Spermicide used alone for contraception. Cochrane Database Syst Rev (2013) 0.77
20 microg versus >20 microg estrogen combined oral contraceptives for contraception. Cochrane Database Syst Rev (2008) 0.77
Immediate start of hormonal contraceptives for contraception. Cochrane Database Syst Rev (2012) 0.77
Steroid hormones for contraception in men: systematic review of randomized controlled trials. Contraception (2005) 0.75
Brief Report: Hormonal Contraception Is Not Associated With Reduced ART Effectiveness Among Women Initiating ART: Evidence From Longitudinal Data. J Acquir Immune Defic Syndr (2017) 0.75
Effect of Pregnancy on Response to Antiretroviral Therapy in HIV-Infected African Women. J Acquir Immune Defic Syndr (2017) 0.75
Spermicide used alone for contraception. Cochrane Database Syst Rev (2013) 0.75
Fertility awareness-based methods for contraception: systematic review of randomized controlled trials. Contraception (2005) 0.75
Do clinical experts rely on the Cochrane library? Obstet Gynecol (2008) 0.75
Quinacrine sterilization and gynecologic cancers: a case-control study in northern Vietnam. Epidemiology (2010) 0.75